NCT05452772 5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder Status RECRUITING Phase PHASE2
NCT05421065 Psilocybin-Assisted vs Ketamine-Assisted Psychotherapy for Alcohol Use Disorder Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05416229 Psilocybin-assisted Therapy for Treatment of Alcohol Use Disorder Status COMPLETED Phase PHASE2
NCT05399498 Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder Status COMPLETED Phase PHASE2
NCT05381974 The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDD Status WITHDRAWN Phase PHASE2
NCT05322954 Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder Status TERMINATED Phase PHASE1
NCT05317689 Comparing the Effects of Psilocin and Psilocybin in Healthy Adults Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05312151 The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder Status COMPLETED Phase PHASE2
NCT05301608 Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought Status RECRUITING Phase PHASE1/PHASE2
NCT05265546 Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the Brain Status RECRUITING Phase PHASE1
NCT05252598 Mood and Cognitive Effects of Psilocybin in Healthy Participants Status WITHDRAWN Phase EARLY_PHASE1
NCT05243329 Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder Status UNKNOWN Phase PHASE2
NCT05242029 Psilocybin for Opioid Use Disorder in Patients on Methadone Maintenance With Ongoing Opioid Use Status WITHDRAWN Phase PHASE2